Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?

European Journal of Haematology

Volumn 78, Issue 2, 2007, Pages 152-156

  Northup, Jill K ^a   Gadre, Swarupa A ^a   Ge, Yimin ^a   Lockhart, Lillian H ^a   Velagaleti, Gopalrao V N ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Dept Pediatrics   (United States)

Author keywords

Burkitt's lymphoma; Clonal abnormalities; Primary effusion lymphoma; Transformation; Translocation

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ASCITES FLUID; BLOOD EXAMINATION; BONE MARROW; BONE MARROW BIOPSY; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CHROMOSOME ABERRATION; CLONAL VARIATION; CYTOGENETICS; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOLOGY; HUMAN; LEUKEMIA; LYMPH NODE; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PLEURA EFFUSION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BURKITT LYMPHOMA; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, X; CLONE CELLS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, MYC; HUMANS; KARYOTYPING; LYMPH NODES; LYMPHOMA, AIDS-RELATED; LYMPHOMA, FOLLICULAR; LYMPHOMA, HIGH-GRADE; MALE; MUTAGENESIS, INSERTIONAL; PLEURAL EFFUSION, MALIGNANT; PREDNISONE; TRANSLOCATION, GENETIC; TRISOMY; VIDARABINE; VINCRISTINE;

EID: 33846112695     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00798.x     Document Type: Article

References (9)

1. Steensma DP, Dewald GW, Hodnefield JM, Tefferi A, Hanson CA. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? Leuk Res 2003;27:235-42.
2. Hain R, Jalali G, Martineau M, McKinley M, Robinson H, Harrison C. Complex chromosomal abnormalities five years before leukemia. Ann Genet 2003;46:122.
3. Shaffer LG, Tommerup N (eds). An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 2005.
4. Huret JL. Atlas of Genetics and Cytogenetics in Oncology and Haematology. (http://www.infobiogen.fr/services/chromcancer/Indexbychrom). May 1998.
5. Horsman DE, Connors JM, Pantzar T, Gascoyne RD. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001;30:375-82.
6. Walts AE, Shintaku IP, Said JW. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 1990;94:170-5.
7. Diebold J, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001:181-4.
8. Wilson KS, McKenna RW, Kroft SH, Dawson DB, Ansari Q, Schneider NR. Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol 2002;116:113-21.
9. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-56.